Clinical effects of indacaterol in patients with COPD

Trial Profile

Clinical effects of indacaterol in patients with COPD

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 May 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 01 Apr 2014 Primary endpoint 'Computerised-tomography-changes' has been met.
    • 01 Apr 2014 Results published in the Respirology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top